Table 4 Antimicrobial resistance profiles of individual colistin-resistant bacterial strains from animal and human sources
From: Emergence of plasmid-mediated mcr genes from Gram-negative bacteria at the human-animal interface
Antibiotics | E. coli | K. pneumoniae | P. aeruginosa | A. baumannii | P. mirabilis | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Animal | Human | Animal | Human | Animal | Human | Animal | Human | Animal | Human | |
(n = 91) | (n = 3) | (n =12) | (n = 1) | (n = 2) | (n = 0) | (n = 0) | (n = 3) | (n = 20) | (n = 10) | |
Co-trimoxazole | 64 (70%) | 3 (100%) | 5 (42%) | 1 (100%) | 2 (100%) | – | – | 3 (100%) | 8 (40%) | 10 (100%) |
Chloramphenicol | 64 (70%) | 3 (100%) | 5 (42%) | 1 (100%) | 2 (100%) | – | – | 3 (100%) | 8 (40%) | 4 (40%) |
Moxifloxacin | 59 (65%) | 2(67%) | 5 (42%) | 1 (100%) | 2 (100%) | – | – | 3 (100%) | 3 (15%) | 4 (40%) |
Levofloxacin | 21 (23%) | 1 (33%) | 3 (25%) | 1 (100%) | 2 (100%) | – | – | 2 (75%) | 3 (15%) | 1 (10%) |
Ciprofloxacin | 38 (42%) | 0 (0%) | 2 (17%) | 1 (100%) | 2 (100%) | – | – | 3 (100%) | 5 (25%) | 1 (10%) |
Co-amoxiclav | 39 (43%) | 2 (67%) | 1 (8%) | 1 (100%) | 0 (0%) | – | – | 3 (100%) | 6 (30%) | 1 (10%) |
Cefotaxime | 35 (38%) | 1 (33%) | 1 (8%) | 1 (100%) | 0 (0%) | – | – | 2 (75%) | 3 (15%) | 1 (10%) |
Cefixime | 29 (32%) | 2 (67%) | 3 (25%) | 1 (100%) | 0 (0%) | – | – | 3 (100%) | 6 (30%) | 3 (30%) |
Cefuroxime | 27 (30%) | 2 (67%) | 0 (0%) | 1 (100%) | 0 (0%) | – | – | 3 (100%) | 7 (35%) | 3 (30%) |
Ceftriaxone | 27 (30%) | 2 (67%) | 1 (8%) | 1 (100%) | 0 (0%) | – | – | 3 (100%) | 7 (35%) | 3 (30%) |
Ceftazidime | 27 (30%) | 1 (33%) | 0 (0%) | 1 (100%) | 0 (0%) | – | – | 3 (100%) | 1 (5%) | 3 (30%) |
Amikacin | 16 (18%) | 1 (33%) | 3 (25%) | 1 (100%) | 0 (0%) | – | – | 2 (75%) | 2 (10%) | 0 (0%) |
Imipenem | 12 (13%) | 1 (33%) | 3 (25%) | 1 (100%) | 0 (0%) | – | – | 1 (33%) | 0 (0%) | 2 (20%) |
Cefoperazone-sulbactam | 7 (8%) | 1 (33%) | 2 (17%) | 1 (100%) | 1 (50%) | – | – | 2 (67%) | 2 (10%) | 0 (0%) |
Piperacillin-tazobactam | 9 (10%) | 0 (0%) | 0 (0%) | 1 (100%) | 0 (0%) | – | – | 0 (0%) | 2 (10%) | 1 (10%) |
Meropenem | 9 (10%) | 1 (33%) | 1 (8%) | 1 (100%) | 0 (0%) | – | – | 3 (100%) | 2 (10%) | 0 (0%) |